Podcasts about Unger

utr

Blir man förvånad av gruppsex på scen? Hur gör man något nytt av Wagner? P1 Kultur pratar om chock och höstens bästa scenupplevelser! Lyssna på alla avsnitt i Sveriges Radio Play. Vi är mitt i senhöstens scensäsong, och det kokar av både experimentella och klassiska föreställningar runt om i landet.Unger programmet delar P1 Kulturs Jenny Teleman, DN:s Kristina Lindquist och Sveriges Radios operakritiker Thomas Nordegren med sig av sina bästa tips!WAGNER-VECKA FRÅN NORRLANDSOPERAN TILL MALMÖ OPERAWagner-feber pågår från norr till söder. I helgen hade både Wagnerklassikerna ”Tristan och Isolde” och ”Lohengrin” premiär, på Norrlandsoperan respektive Malmö Opera.Hur lyckade är de nya uppsättningarna? Vad är historierna bakom operaklassikerna? Och hur sätts de upp och blir nya i vår tid? Thomas Nordegren och Kristina Lindquist har sett dem.SAMLAG PÅ SCEN I DRAMATENS UNGERSKA GÄSTSPEL – VAD TILLFÖR NAKENCHOCKEN?Jenny Teleman har sett det ungerska gästspelet ”Parallax” på Dramaten i Stockholm, och kallar det fenomenalt. I pjäsen skildras generationstrauman, judisk identitet och queerhet med flera uppseendeväckande effekter – bland annat är flera skådespelare nakna i en gruppsexscen.Hur fungerar greppet chock på scen idag? Vad blir publiken chockad av, och hur har det förändrats under årens teatersäsonger? Jenny Teleman och Kristina Lindquist diskuterar.CLAES MALMBERG OCH PIA JOHANSSON GÖR LÅNGTURNÉ MED STRINDBERGS ”DÖDSDANSEN”Ikväll inleds Riksteaterns långturné med August Strindbergs klassiker ”Dödsdansen”. Claes Malmberg och Pia Johansson spelar paret Edgar och Alice, som efter ett långt liv tillsammans bara pratar i giftiga repliker.P1 Kulturs Björn Jansson har gått bakom scenen och träffat skådespelarna i Riksteaterns lokaler.BARNRADIONS BOKPRIS: OM SKAM I ”DET ÄR EN EVIGHET TILL STJÄRNORNA”Barnradions jury diskuterar Conny Palmkvists ”Det är en evighet till stjärnorna”, som handlar om Gunnar, som gör allt för att smälta in i skolan. Något som inte är det enklaste när man har en syster med en funktionsvariation. Juryn ringer upp författaren och pratar om familj och skam!Juryn består av Atle Thorén, Lisa Müntzing Brolin, Astrid Knape, Latifa Esmailian Malm och Majken Wetterstrand från Möllevångsskolan i Malmö. De pratar om bokprisets nominerade böcker i varsitt avsnitt under vecka 44, och utser sedan den bästa. Vinnaren avslöjas i den stora finalen söndag 2 november kl. 12:03 i P4.Programledare: Saman BakhtiariProducent: Sara Ek

Gideon - Trumpet Pastor Lisa 10/26/25

utr

On this week's Talkhouse Podcast, we've got two British gentlemen who made big waves in the past couple of decades and who've collided just recently for a celebratory remix: It's Tom Vek and Gus Unger-Hamilton. Tom Vek released his instant-classic debut We Have Sound back in 2005, putting his own spin on post-punk and dance and riding the wave of so-called “indietronica” with catchy tracks like “Nothing But Green Lights.” He hasn't exactly been prolific since then, releasing quality albums every few years while also working hard in other areas of the industry: Check out both supercollector.com and his upcoming music player, Sleevenote. But in celebration of We Have Sound's 20th anniversary, Vek asked a bunch of friends and fellow musicians to remix each of the album's tracks, including folks like Baths, Glass Animals, and the other half of today's conversation, Gus Unger-Hamilton of the band Alt-J. Check Unger-Hamilton's remix of Vek's song “Cover” right here. It's unsurprising that Unger-Hamilton put his own spin on Vek's song: Alt-J has been scribbling in the bombastic, weirder corners of indie-rock and art-rock for since 2007, though they didn't release their big debut, An Awesome Wave, until 2012. They've since embraced their oddness on a string of records, with the latest being 2022's The Dream, which was hailed at the time as a return to the power of their debut. New music is likely on the horizon, though as you'll hear in this chat, Alt-J is currently without a label home.  Label homes are one of many things these two chat about in this lively conversation: They're both into the logos of their favorite record companies, they're both really into fancy watches, and they're both back into the lost art of reading a good book. Though Gus admits he hasn't read a particular novel that his band famously borrowed a title from. Listen and find out which one. Thanks for listening to the Talkhouse Podcast, and thanks to Tom Vek and Gus Unger-Hamilton for chatting. If you liked what you heard, please follow Talkhouse on your favorite podcasting platform, and check out all the great stuff at Talkhouse.com. This episode was produced by Myron Kaplan, and the Talkhouse theme is composed and performed by The Range. See you next time!   Find more illuminating podcasts on the ⁠⁠⁠Talkhouse Podcast Network⁠⁠⁠. Visit ⁠⁠⁠talkhouse.com⁠⁠⁠ to read essays, reviews, and more. Follow @talkhouse on ⁠⁠⁠Instagram⁠⁠⁠, ⁠⁠⁠Bluesky⁠⁠⁠, ⁠⁠⁠Twitter (X)⁠⁠⁠, ⁠⁠⁠Threads⁠⁠⁠, and ⁠⁠⁠Facebook⁠⁠⁠.

Unger, Max-Marian www.deutschlandfunk.de, Tag für Tag

Click here to register for my FREE Masterclass: https://autc.pro/TSSeng-pod?utm_source=spreaker&utm_medium=poden&utm_content=476&sl=spreaker-poden-476

Clicca qui per iscriverti alla Masterclass gratuita:  https://autc.pro/TSSita-pod?utm_source=spreaker&utm_medium=podit&utm_content=477&sl=spreaker-podit-477

Wie Gefühle Kaufentscheidungen prägen und Marken erfolgreich machen Die eCommerce-Welt ist schnelllebig, hart umkämpft und von einem Überangebot geprägt. Genau deshalb spielt die emotionale Markenbindung eine zentrale Rolle für den nachhaltigen Erfolg von Unternehmen. Markenführung darf sich nicht auf Logos, Farben oder Slogans beschränken – sie muss tief in das Bewusstsein der Konsumenten eindringen und eine Verbindung schaffen, die über rationale Argumente hinausgeht. Dieses Webinar zeigt praxisnah, wie Emotionen Kaufentscheidungen beeinflussen und warum Markenführung heute mehr denn je auf Authentizität und Konsistenz setzen sollte. Denn nur wenn Werte, Botschaften und Auftritt einer Marke klar und einheitlich vermittelt werden, entsteht langfristiges Vertrauen. Kunden, die sich emotional abgeholt fühlen, bleiben nicht nur länger, sondern entwickeln echte Loyalität. Das erwartet Dich im Webinar: - Die Bedeutung von Emotionen in der Markenführung: Warum Gefühle oft stärker wirken als rationale Argumente. - Strategien für nachhaltige Kundenbindung: Wie Unternehmen emotionale Trigger bewusst einsetzen können. - Praxisnahe Techniken: Methoden, mit denen sich positive Emotionen gezielt in der Markenkommunikation verankern lassen. - Die Rolle von Konsistenz und Authentizität: Wie klare Botschaften Vertrauen und Wiedererkennungswert schaffen. - Best Practices aus der Praxis: Erfolgreiche Beispiele, die zeigen, wie Marken emotionale Bindungen aufbauen und Kunden langfristig begeistern. Darüber hinaus erhältst Du konkrete Ansätze, wie Du Deine Zielgruppen besser verstehst, ihre Bedürfnisse analysierst und die emotionale Ansprache strategisch in Dein Marketing integrierst. Das Ergebnis: Kunden, die nicht nur kaufen, sondern wiederkommen – und Marken, die sich nachhaltig im Gedächtnis verankern. Das wirst Du nach dem Webinar gelernt haben: - Bedeutung der Emotionen: Verstehen, warum emotionale Bindungen wichtiger sind als rationale Überlegungen bei Kaufentscheidungen. - Aufbau einer starken Marke: Techniken zur Schaffung einer Marke, die beim Konsumenten positive Emotionen weckt. - Konsistenz in der Markenführung: Die Notwendigkeit, konsistent und authentisch in der Markenkommunikation zu sein. - Zielgruppenanalyse: Erlernen, wie man Zielgruppen analysiert und deren emotionale Trigger identifiziert. - Erfolgsfaktoren: Wichtige Faktoren, die den Erfolg einer Marke beeinflussen, wie Storytelling, visuelle Identität und Kundenerfahrung. - Messinstrumente: Kennenlernen von Tools und Methoden zur Messung der emotionalen Markenbindung und deren Auswirkungen auf Kaufentscheidungen.

Gideon - Light Pastor Lisa 10/19/25

In 1814, as Napoleon's fortunes turn for the worse, Lafayette considers returning to politics. Unwilling to sit idle while the survival of the nation was at stake, he was determined to rekindle the flame of liberty- or at least to do what he could to avert a total catastrophe. Email me: perspectivesinhistorypod@gmail.com Podcast Website Follow me on Twitter Facebook Page Buy Some Used Books Bibliography Auricchio, Laura. The Marquis: Lafayette Reconsidered. Vintage Books, 2015. Babeau, Emile and Maurice de la Fuye. The Apostle of Liberty: A Life of Lafayette. Thames and Hudson, 1956.  Duncan, Mike. Hero of Two Worlds: The Marquis de Lafayette in the Age of Revolution. Hachette Book Group, 2021.  Israel, Jonathan. The Expanding Blaze: How the American Revolution Ignited the World, 1775-1848. Princeton University Press, 2011.  Kramer, Lloyd S. Lafayette in Two Worlds: Public Cultures and Personal Identities in an Age of Revolutions. University of North Carolina Press, 1996. Lafayette, Marie Joseph Paul Yves Roch Gilbert Du Motier. Memoirs, Correspondence, and Manuscripts of General Lafayette, vols 1-6. Saunders and Otley, 1837.  Schama, Simon. Citizens: A Chronicle of the French Revolution. Alfred A. Knopf, 1989.  Unger, Harlow Giles. Lafayette. John Wiley & Sons, Inc, 2002. Woodward, W.E. Lafayette. Farrar & Rinehart, 1938. Cover Image: Portrait of Gilbert Motier the Marquis De Lafayette as a Lieutenant General, 1791. Painting by Joseph-Désiré Court, 1834. Closing theme: "Ça Ira" (It will be fine)- popular song from the French Revolution.

Dr. Monty Pal and Dr. Fumiko Chino discuss several of the top abstracts presented at the 2025 ASCO Quality Care Symposium, including research on federally funded clinical trials and financial reimbursement for trial participation. TRANSCRIPT Dr. Monty Pal: Hello, and welcome to the ASCO Daily News Podcast. I am your host, Dr. Monty Pal. I am a medical oncologist, professor, and vice chair of academic affairs at the City of Hope Comprehensive Cancer Center in Los Angeles. Today, we are highlighting key abstracts that were presented at the 2025 ASCO Quality Care Symposium. I am delighted to be joined today by the chair of this year's meeting, Dr. Fumiko Chino. Dr. Chino is an associate professor in radiation oncology at MD Anderson Cancer Center with a research focus on access, affordability, and equity. She is also a consultant editor of JCO Oncology Practice and the host of the Put into Practice podcast. I have got to listen to that.  Dr. Chino, welcome, and thanks so much for being on the podcast today. Dr. Fumiko Chino: I am overjoyed to be here, and absolutely, you should take a listen. Dr. Monty Pal: Definitely. And FYI for listeners, our full disclosures are all available in the transcript of this episode, so do have a look if you are inclined. Now, we have really seen some fantastic advances in health services and quality and supportive care, digital health, and beyond. There are some great abstracts that were presented at this year's meeting. I have actually picked a couple that I am particularly interested in and that I believe you share my interest in as well.  So, the first is an abstract actually from my friends at SWOG (Abstract 94). So, this was a terrific abstract from Joe Unger and Michael LeBlanc and Dawn Hershman. And this, I think, really hits on a very, very key issue right now, which is the benefit of federally funded trials. Do you mind just kind of spelling out some of the observations from what I think is a really brilliant piece of work? Dr. Fumiko Chino: Absolutely, and I think Dr. Unger's work is really important for our current funding environment. I think that this research is really essential to do to show the role of federal sponsorship in the design and conduct of clinical trials. Because what they did was really look at a landscape analysis over the last 20 years looking at funding and were able to show quite clearly that federal funding really matters for advancing the science in cancer care. So what they showed was that the federal funding was more commonly essential for early-stage clinical trials, so those phase 1, phase 2 trials that really help advance the science. And that federal funding was really essential for multimodality drug combinations, combinations with drug and surgery, combinations with drug and radiation. Those trials were much more likely to be federal funded. And then the last thing is that they showed that the patients that are, I think, the largest at risk for gaps in care who really need the advancements in science that keep U.S. health care amazing and wonderful and world-leading, so the kids, the pediatric patients, the patients with rare cancers, and the patients actually that could benefit from de-escalation or right-sizing of treatment, they were also all more likely to have federal funding. So I think this research that was presented really shows that if, unfortunately, current status of restricted federal funding continues, that we are going to lose out in terms of the next generation of cancer cures, cancer de-escalations, and the type of combination treatments that make advancements in science. Dr. Monty Pal: Indeed. You know, I always point to Joe Unger's paper, and I think it is in JAMA Oncology, right, that showed life-years gained from NCI trials. It is such an important piece of work. I think this is a really nice complement to that, isn't it, to show the specific areas that otherwise would be, am I right in saying, kind of largely untouched? Dr. Fumiko Chino: I think you are right in that what we know from what industry will sponsor versus what the federal government will sponsor, that the federal government really helps make up the gap to really make those advancements that save lives, that lead to more birthdays, that advance our knowledge and our capacity for providing more cures and more successful futures for our patients. I always like pointing to the de-escalation research, which is, and this is not to dig pharma, but no pharmaceutical company is going to run a trial that says you can give less of their drug, right? It just does not make sense for the business end of the science. And so, thinking about how to right-size treatments, how to do more with less, that really is the purview of the federal government. Dr. Monty Pal: Absolutely. Absolutely.  I am going to shift gears here and bring up another abstract that I found to be quite intriguing, and this relates to reimbursement of expenses, et cetera, for clinical trials. This is an abstract from Courtney Williams and team. It brings to mind the importance, I think, of recognizing the hardships that patients take on by clinical trials, but I also would love for you to comment on that sort of fine line between reimbursement for expenses and then, you know, sort of undue enticement. It is a challenging balance there. But give me your reflections on this abstract. Dr. Fumiko Chino: Absolutely. You are speaking about Dr. Williams' Abstract 93 from the Alabama group, and Alabama actually has this incredible group of health services researchers which is, are doing really important work in this space. What this trial shows is that, you know, it is a small pilot study, it is 30-something patients that received some support primarily for their travel and additional expenses related to their clinical trial participation for breast cancer. It showed that the money helps, and I think what we all know is that it is expensive to participate in clinical trials. It requires additional visits. It often requires some significant travel burden for our patients, and I do not feel that money reimbursement for clinical trial expenses is an inducement. Nobody participates in a clinical trial to get the money for their gas, right? We know that our patients are making some pretty significant sacrifices in order to participate in clinical trials, and what this type of program does is just actually reimburse them for their outlaying of funds.  And I loved this trial because the patients were actually given $1,000 a month for the first 4 months of their trial participation, and what the study showed is that the patients were using it for things like travel-related food, for things like transportation, caregiver expenses, or even some of their out-of-pocket medical expenses like cost sharing or prescriptions. And that they said that overall, the reimbursement really made a difference in terms of their capacity for staying on the clinical trial. Because we know our clinical trials really are not able to enroll the full diversity of patients that often have a disease, and that the patients that are at biggest risk for a health care disparity or a gap in care are also the least likely to enroll in a clinical trial.  Programs like this are an essential part of showing how financial toxicity can be overcome with pretty straightforward assistance to patients to help reimburse them for the things that they are already taking out of their pocket, for parking costs, for that $10 soup that they buy at the cancer center, for those additional expenses that we are, unfortunately, putting on them. Dr. Monty Pal: Very well said. And you know, I have started to dabble in clinical trials looking at CAR T-cell therapies for kidney cancer, and I have to tell you, it is just insane the amount of cost that a patient would have to take on to comply with the stipulations for some of these novel therapies. We require that they stay within 30 minutes of the facility for 28 days, and unless we are compensating for some of that, I mean, how can one afford a hotel stay that is that long? I mean, it is just, it is unprecedented, and it would certainly provide a huge barrier to many patients who would otherwise enroll. Really well said. I also wanted to bring up another financially driven topic, and treating renal cell, again, I would say the vast majority, 90% plus of my patients in clinic are on oral drug therapies. And I cannot tell you how often a patient will show up in my practice and say, "Doc, I have got 15 days out of this 30-day prescription left. What do I do with it?" You know, or some come with pill bottles from a deceased loved one. And it is so frustrating to say, "Take it to the pharmacy and they will just get rid of it for you." But sounds like there is an abstract from Dr. Mackler, Abstract 102, that seems to address this topic quite well. Am I right? Dr. Fumiko Chino: Absolutely. This presentation, I was the most excited about seeing because this group, which helps run a cancer drug repository, theirs is called YesRx, presented their data from the last approximately two years of running this repository, and they were able to show incredible benefit for their patients in Michigan. And it is a really straightforward program. It is run by pharmacists. It has support from the legislation in Michigan. And what they were able to show is that they repurposed medications that would otherwise have been discarded. They delivered them directly to the oncologist, which then actually dispersed them to the patients. They helped 1,000 patients in less than two years. They saved them millions of dollars, over $15 million presented in the abstract. And it is just a win-win-win because I know that patients actually, and sometimes patient caregivers, they feel very sad to have spent a lot of money out of pocket for their medication, and then if they have a dose reduction or, obviously, you know, if the surviving spouse then has to get rid of their medication, just dispose of them, it is very disheartening. And this is a way of kind of reclaiming power for patients. So they were able to accept donations from all over the state of Michigan and then also help over 1,000 patients. And so, it is a phenomenal program. Dr. Monty Pal: Just wild when I came across the dollar amounts, right, that they were saving. It just, it seems like a place that, you know, we just have to look, as cancer centers, right, and really take this on. Just brilliant. On that same theme of cost savings and so forth, you know, I think there has been a lot of focus on what recent policies have done in the context of us having access to therapies and so forth. And one of the topics that has come up is the Inflation Reduction Act and how changes pertaining to the IRA have really played a role in one's ability to take on some of these expensive prescriptions. And I believe John Lin and colleagues tackled that issue in Abstract 97. Could you comment on that, Fumiko? Dr. Fumiko Chino: Absolutely. Dr. Lin is one of my colleagues here at MD Anderson, so I know him very well, and he has been doing really phenomenal work over the last several years with looking at drug affordability and access. And what his analysis shows is that for patients, after the Inflation Reduction Act's cap on out-of-pocket expenses, is that it really did show that out-of-pocket expenses decreased. So what the Inflation Reduction Act did is that it eliminated the 5% co-insurance and placed this $2,000 cap on out-of-pocket expenses. And what that led to for these patients that were not able to have the low-income subsidy is that there were lower costs, and that there was a lower rate of drug abandonment, meaning that the prescription was not refilled. There was also a lower rate of unfilled prescriptions as well. And I think that it shows that health policy really can improve access to care. I think the flip side of the fact that the IRA, this policy, really did seem to help people is that what his research showed is that actually, even with the benefits of this cap, is that actually it is still really high in terms of the rate of people who are not able to fill their prescriptions or that completely abandon them over time. And that unfortunately, even with this change, that over half of people without the low-income subsidy were potentially not getting the full benefit of their medications because they were not able to afford them. And so I think it really kind of highlights that we still need to do more work about making drugs affordable. Dr. Monty Pal: Indeed, indeed. And I mean, in a setting like this, I mean, I think it is important to recognize that $2,000 is a lot, it is a big chunk of change, right, for a lot of families in the U.S. What do you think of the prospect of, like, decreasing that cap? Is that something that from a policy standpoint you would be supportive of? Dr. Fumiko Chino: Well, so something that is a real option for patients on Medicare is there is something called the Medicare Prescription Payment Plan, and what it allows you to do is actually prorate the $2,000 over the whole year. And so instead of having to pay $2,000 as soon as you fill your prescription, because you are going to have, if you have an expensive medication, it is essentially you have to pay the $2,000 in January, right? It allows you to prorate it, so essentially $170 a month, and that comes to you as like a regular bill. And I think that as rolled out as part of the IRA is a really lovely way of thinking about how do we make these payments more stable over time, so it is not a huge hit sort of at the beginning of the year. And I think that alone actually can make a difference in terms of trying to help make sure that people can actually get their medications. Dr. Monty Pal: That is an excellent tip. Excellent tip.  We are going to shift gears entirely. We have been talking a lot about the dollars and cents of things and talk about an abstract from Sophia Smith and colleagues. So this is Abstract 550 at your meeting. And this hinged on a program of sorts to deal with post-traumatic stress disorder. We do not often think about PTSD in the vernacular for oncology patients, but indeed, I mean, it is something that they must face, especially in the context of long-term survivorship. Can you talk a little bit about Dr. Smith's abstract? Dr. Fumiko Chino: Absolutely. I love this work from Dr. Smith, who is at Duke. She worked with Dr. Applebaum, who was my old colleague at Memorial Sloan Kettering. And this group of researchers really is trying to figure out how to best support people into survivorship so that they can actually thrive. And their patient population for this work was actually people who received stem cell transplant, and they focused on people who had PTSD symptoms. And what they were able to show through this SMART design, which is essentially this serial, multiple randomized trial, so everyone got randomized upfront to either usual care or this app, so this digital app that actually helped coach people through cancer distress. And then for the people who were non-responders, they were then additionally randomized to either the app plus coaching or a therapist versus the cognitive behavioral therapy or CBT.  And what they were able to show is that, number one, anyone who had the app seemed like they did better than those who did not start the path with the app. But then the additional help of either the therapist or the coach or the CBT made additional benefit over time. And so, I think this shows a really nice stepped care, which is you can potentially have some right-sizing of treatments cost saving, if we sort of give everyone the app, which is, I think, overall pretty low cost. And that for the people who do not get the full benefit from the app, then you can think about these maybe more tailored approaches, the therapist, the coach, the CBT, but that some people actually just respond to the app. And I think it allows us to, again, right-size the care for our patients. And I think it is really innovative to think about how technology can help improve access to care in the setting of something like PTSD. Dr. Monty Pal: Brilliant summary. Brilliant summary.  Gosh, it looks like such an exciting meeting this year. Congratulations on a terrific program for the ASCO Quality Care Symposium. I know you played a huge role in developing it, and thanks for sharing your insights on the ASCO Daily News Podcast. Dr. Fumiko Chino: No, I really appreciate you having me. ASCO Quality is my favorite meeting of the year. You know, it is really a phenomenal meeting, and I am so excited for next year in Boston in 2026. Dr. Monty Pal: Awesome. And thanks to our listeners too. You are going to find links to all the abstracts that we discussed today in the transcript of this episode. Finally, if you value the insights that you heard today on the ASCO Daily News Podcast, please rate, review, and subscribe wherever you get your podcasts. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity or therapy should not be construed as an ASCO endorsement. More on today's speakers: Dr. Sumanta (Monty) Pal  @montypal Dr. Fumiko Chino @fumikochino Follow ASCO on social media: @ASCO on Twitter ASCO on Bluesky ASCO on Facebook ASCO on LinkedIn Disclosures of Potential Conflicts of Interest: Dr. Monty Pal:     Speakers' Bureau: MJH Life Sciences, IntrisiQ, Peerview Research Funding (Inst.): Exelixis, Merck, Osel, Genentech, Crispr Therapeutics, Adicet Bio, ArsenalBio, Xencor, Miyarsian Pharmaceutical Travel, Accommodations, Expenses: Crispr Therapeutics, Ipsen, Exelixis Dr. Fumiko Chino:  Consulting or Advisory Role: Institute for Value Based Medicine Research Funding: Merck

Gideon - Men Who Carry Pitchers Pastor Lisa 10/12/25

utr

Unger, Kolja www.deutschlandfunk.de, Corso

Jim Murray - Hope Jim Murray 10/05/25

Regaining his freedom after five years in prison, Lafayette emerges into a world irrevocably changed by the revolution he helped put into motion. Now considered a political liability by the governments of both France and the United States, and with war continuing to rage across Europe, his future appeared more uncertain than ever. Email me: perspectivesinhistorypod@gmail.com Podcast Website Follow me on Twitter Facebook Page Buy Some Used Books Bibliography Auricchio, Laura. The Marquis: Lafayette Reconsidered. Vintage Books, 2015. Babeau, Emile and Maurice de la Fuye. The Apostle of Liberty: A Life of Lafayette. Thames and Hudson, 1956.  Duncan, Mike. Hero of Two Worlds: The Marquis de Lafayette in the Age of Revolution. Hachette Book Group, 2021.  Israel, Jonathan. The Expanding Blaze: How the American Revolution Ignited the World, 1775-1848. Princeton University Press, 2011.  Kramer, Lloyd S. Lafayette in Two Worlds: Public Cultures and Personal Identities in an Age of Revolutions. University of North Carolina Press, 1996. Lafayette, Marie Joseph Paul Yves Roch Gilbert Du Motier. Memoirs, Correspondence, and Manuscripts of General Lafayette, vols 1-6. Saunders and Otley, 1837.  Schama, Simon. Citizens: A Chronicle of the French Revolution. Alfred A. Knopf, 1989.  Unger, Harlow Giles. Lafayette. John Wiley & Sons, Inc, 2002. Woodward, W.E. Lafayette. Farrar & Rinehart, 1938. Cover Image: Portrait of Gilbert Motier the Marquis De Lafayette as a Lieutenant General, 1791. Painting by Joseph-Désiré Court, 1834. Closing theme: "Ça Ira" (It will be fine)- popular song from the French Revolution.

utr

Unger, Kolja www.deutschlandfunk.de, Corso

Have you ever wondered about the 408 mile thru-hike of the Jordan Trail? Listen in to this episode featuring uber experienced thru-hikers and backpackers Ryan "Ungerwhere" Unger and Ben "Neon" Craver as they discuss strategy, culture, and common thru-hiking aspects to keep in mind.This is part 2 of a 2 part series. Check out Episode #217 for part 1 on the Jordan Trail!In this episode, you'll learn about:The visa, water, and resupply situationBest months to hike the trailHitchhiking and cultural experiencesThe best resources to use & more!Applicable Links:The Jordan Trail WebsiteFarOutGaia GPSConnect with Ryan "Ungerwhere" Unger:⁠⁠Ungerwhere's Website⁠⁠⁠⁠⁠⁠Ungerwhere's YouTube Channel⁠⁠⁠Ungerwhere's Instagram⁠⁠Connect with Ben "Neon" Craver:⁠Neon's Instagram⁠Help fellow hikers find the show by following, rating, and reviewing the podcast on ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Spotify⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Apple Podcasts⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠!Connect With THRU-r & Cheer:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Join The Trail Family⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠THRU-r Website⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠THRU-r Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠THRU-r Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠THRU-r Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠THRU-r Threads⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Cheer's YouTube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Cheer's Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Episode Music: "Communicator" by Reed Mathis

Gideon - Reduced or Enlarged Pastor Lisa 09/28/25

utr

Have you ever wondered about the 408 mile thru-hike of the Jordan Trail? Listen in to this episode featuring uber experienced thru-hikers and backpackers Ryan "Ungerwhere" Unger and Ben "Neon" Craver as they recount their trek through diverse terrain and culturally rich country - which also came with some highs and lows.This is part 1 of a 2 part series. Check out Episode #218 dropping this week for more from the Jordan Trail!In this episode, you'll learn about:The best tips, tools, and tricks to use for information and successAnimals you'll likely see on trailSurprisingly diverse terrain and the not-to-miss spots you'll encounterThe water situation, cultural notes, & much more!Connect with Ryan "Ungerwhere" Unger:⁠Ungerwhere's Website⁠⁠⁠⁠Ungerwhere's YouTube Channel⁠Ungerwhere's Instagram⁠Connect with Ben "Neon" Craver:Neon's InstagramHelp fellow hikers find the show by following, rating, and reviewing the podcast on ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Spotify⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Apple Podcasts⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠!Connect With THRU-r & Cheer:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Join The Trail Family⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠THRU-r Website⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠THRU-r Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠THRU-r Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠THRU-r Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠THRU-r Threads⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Cheer's YouTube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Cheer's Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Episode Music: "Communicator" by Reed Mathis

In this episode, host Lee Smalt interviews Amy Sundin Unger, Executive Director of Gunner School, about building accessible motion design education and fostering community connections, with Camp MoGraph recaps from Jen, EJ, Kons, and Moe.This episode covers:Camp MoGraph highlights: Creative community activities including yearbook creation, projection mapping experiences, scavenger hunts, and the return of authentic networking magic at Silver Beach YMCAAccessible education model: Gunner School's 12-week choose-your-own-adventure curriculum combining in-studio and online learning, focusing on soft skills alongside technical developmentCommunity-first learning philosophy: How removing barriers like cost and location while emphasizing peer connections creates stronger educational outcomes than traditional programsStudio partnership expansion: Current model with Box Fort Detroit and Lunar North, seeking 5 additional partner studios across the USMentorship network building: Practical advice for emerging artists to build peer networks and overcome anxiety about reaching out to industry professionalsFlexible curriculum design: Why rapid adaptation to industry changes and feedback loops are essential for modern creative education programsUpcoming Events:Next Monday: Open discussion on community building with Austin Saylor Game night planning for October (Gartic Phone returns)Gunner School seeking mentor volunteers and studio partnerships nationwideVisit MondayMeeting.org for this episode and other conversations from the motion design community!SHOW NOTES:⁠⁠⁠Monday Meeting Patreon⁠⁠⁠⁠⁠⁠Monday Meeting Discord⁠⁠⁠⁠⁠⁠MondayMeeting LinkedIn⁠⁠⁠⁠⁠⁠MondayMeeting Instagram⁠⁠⁠⁠⁠⁠MondayMeeting Bluesky⁠⁠⁠⁠⁠⁠MondayMeeting Newsletter⁠Gunner SchoolAmy's LinkedInSync Sketch

Click here to register for my FREE Masterclass: https://autc.pro/TSSeng-pod?utm_source=spreaker&utm_medium=poden&utm_content=475&sl=spreaker-poden-475

HEADLINE: Inside the Den of Spies: Iran Visit and Confessions of an Arms Procurement ChiefAUTHOR: Craig Unger SUMMARY: While investigating in Iran, Craig Unger visited the former US Embassy, known as the Den of Spies, now a spy museum. He secured a brief meeting with Mohsen Rafighdoost, former head of arms procurement for Ayatollah Khomeini, who accidentally referenced meeting with Republicans—a statement Unger captured on video, lending credence to the secret deal. Retry JB

Gideon - Christ in Judges Pastor Lisa 09/21/25

Arrested by the Austrians after escaping political persecution in France, Lafayette is locked away in a dungeon for refusing to betray his ideals. While his family and friends, scattered across the world, do what they can to aid him, it becomes increasingly clear as time went on that his salvation would come from the same nation that had once scorned him. Email me: perspectivesinhistorypod@gmail.com Podcast Website Follow me on Twitter Facebook Page Buy Some Used Books Bibliography Auricchio, Laura. The Marquis: Lafayette Reconsidered. Vintage Books, 2015. Babeau, Emile and Maurice de la Fuye. The Apostle of Liberty: A Life of Lafayette. Thames and Hudson, 1956.  Duncan, Mike. Hero of Two Worlds: The Marquis de Lafayette in the Age of Revolution. Hachette Book Group, 2021.  Israel, Jonathan. The Expanding Blaze: How the American Revolution Ignited the World, 1775-1848. Princeton University Press, 2011.  Kramer, Lloyd S. Lafayette in Two Worlds: Public Cultures and Personal Identities in an Age of Revolutions. University of North Carolina Press, 1996. Lafayette, Marie Joseph Paul Yves Roch Gilbert Du Motier. Memoirs, Correspondence, and Manuscripts of General Lafayette, vols 1-6. Saunders and Otley, 1837.  Schama, Simon. Citizens: A Chronicle of the French Revolution. Alfred A. Knopf, 1989.  Unger, Harlow Giles. Lafayette. John Wiley & Sons, Inc, 2002. Woodward, W.E. Lafayette. Farrar & Rinehart, 1938. Cover Image: Portrait of Gilbert Motier the Marquis De Lafayette as a Lieutenant General, 1791. Painting by Joseph-Désiré Court, 1834. Closing theme: "Ça Ira" (It will be fine)- popular song from the French Revolution.

utr

Unger, Kolja www.deutschlandfunk.de, Corso

utr

Unger, Kolja www.deutschlandfunk.de, Corso

Unger, Kolja www.deutschlandfunk.de, Corso

10 Miles Past Victory Pastor Lisa 09/07/25

Lafayette's persistent efforts to save the French monarchy end in failure when Louis XVI is overthrown once and for all in August 1792. With his avowed enemies, the Jacobins, now in power and accusing him of betraying the revolution, the general is faced with the most difficult decision of his life. Email me: perspectivesinhistorypod@gmail.com Podcast Website Follow me on Twitter Facebook Page Buy Some Used Books Bibliography Auricchio, Laura. The Marquis: Lafayette Reconsidered. Vintage Books, 2015. Babeau, Emile and Maurice de la Fuye. The Apostle of Liberty: A Life of Lafayette. Thames and Hudson, 1956.  Duncan, Mike. Hero of Two Worlds: The Marquis de Lafayette in the Age of Revolution. Hachette Book Group, 2021.  Israel, Jonathan. The Expanding Blaze: How the American Revolution Ignited the World, 1775-1848. Princeton University Press, 2011.  Kramer, Lloyd S. Lafayette in Two Worlds: Public Cultures and Personal Identities in an Age of Revolutions. University of North Carolina Press, 1996. Lafayette, Marie Joseph Paul Yves Roch Gilbert Du Motier. Memoirs, Correspondence, and Manuscripts of General Lafayette, vols 1-6. Saunders and Otley, 1837.  Schama, Simon. Citizens: A Chronicle of the French Revolution. Alfred A. Knopf, 1989.  Unger, Harlow Giles. Lafayette. John Wiley & Sons, Inc, 2002. Woodward, W.E. Lafayette. Farrar & Rinehart, 1938. Cover Image: Portrait of Gilbert Motier the Marquis De Lafayette as a Lieutenant General, 1791. Painting by Joseph-Désiré Court, 1834. Closing theme: "Ça Ira" (It will be fine)- popular song from the French Revolution.

Kim Huntley Speaks Kim Huntley 08/31/25

utr

In this episode, Dr. E is joined by Dr. Chance Unger. Chance discovered his passion for running in college and found as a DPT, he had a unique ability to help those that needed to keep their passion going. You can find Chance's amazing resource on running here or go to his websiteUntold Physio Stories is sponsored by⁠Comprehend PT⁠- Leave Comprehend PT running in the background or record audio when you have time. The AI based SOAP note generator does the rest! No need for accuracy or exact wording! It's a game changer and will give you more time with your patients! Use code MMT50 to save 50% off your first month. Free trial available at sign up!⁠⁠The Eclectic Approach Network⁠⁠ - Check out Dr. E's all new private, non tracking and ad free network for rehab pros! It's free to join, has chat, feed, and all the features of other social networks without the creeping tracking.Check out ⁠⁠EDGE Mobility System⁠⁠'s Best Sellers - Something for every PT, OT, DC, MT, ATC or Fitness Minded Individual https://edgemobilitysystem.com

Click here to register for my FREE Masterclass: https://autc.pro/TSSeng-pod?utm_source=spreaker&utm_medium=poden&utm_content=473&sl=spreaker-poden-473

Pastor Jeremy Hiles Pastor Jeremy Hiles 08/24/25

UTR

Ungerührt von internationaler Kritik treibt Israel den umstrittenen Siedlungsbau in der Westbank voran und setzt seine Offensive auf Gaza-Stadt fort. Welche Pläne verfolgt die Regierung? Und warum die Debatte in Deutschland darüber so verdruckst ist. (15:40) Philipp May

UTR

Baptism Pt.3 Pastor Lisa 08/10/25

UTR

Susan Oxley and Dr. Corinne Unger are back again to discuss the implementation of the three climate resolutions passed at the 2025 Community of Christ World Conference. Dr. Unger, an expert in earth science and associated risk management strategies, highlights the importance of local environmental actions and the need for global coordination. She suggests a collaborative approach, involving bi-annual meetings, to align efforts and address vulnerabilities, and emphasizes the need for practical, manageable steps and leveraging existing resources to achieve the resolutions' goals.Other recent episodes with Dr Unger: 874 | Climate Brewing | Mine Closures and Indigenous Peoples 875 | Climate Brewing | Phases of Mine ClosuresDownload the TranscriptThanks for listening to Project Zion Podcast!Follow us on Facebook and Instagram!Intro and Outro music used with permission: “For Everyone Born,” Community of Christ Sings #285. Music © 2006 Brian Mann, admin. General Board of Global Ministries t/a GBGMusik, 458 Ponce de Leon Avenue, Atlanta, GA 30308. copyright@umcmission.org “The Trees of the Field,” Community of Christ Sings # 645, Music © 1975 Stuart Dauerman, Lillenas Publishing Company (admin. Music Services). All music for this episode was performed by Dr. Jan Kraybill, and produced by Chad Godfrey. NOTE: The series that make up the Project Zion Podcast explore the unique spiritual and theological gifts Community of Christ offers for today's world. Although Project Zion Podcast is a Ministry of Community of Christ. The views and opinions expressed in this episode are those speaking and do not necessarily reflect the official policy or position of Community of Christ.

The explosive inside story of the October Surprise conspiracy, a stunning act of treason that changed American history. New York Times bestselling author Craig Unger reveals his thirty-year investigation into the secret collusion between Ronald Reagan's 1980 presidential campaign and Iran, raising urgent questions about what happens when foreign meddling in our elections goes unpunished and what gets remembered when the political price for treason is victory.It was a tinderbox of an accusation. In April 1991, the New York Times ran an op-ed alleging that Ronald Reagan's 1980 presidential campaign had conspired with the Iranian government to delay the release of 52 American hostages until after the 1980 election. The Iranian hostage crisis was President Jimmy Carter's largest political vulnerability, and his lack of success freeing them ultimately sealed his fate at the ballot box. In return for keeping Americans in captivity until Reagan assumed the oath of office, the Republicans had secretly funneled arms to Iran. Treasonous and illegal, the operation—planned and executed by Reagan's campaign manager Bill Casey—amounted to a shadow foreign policy run by private citizens that ensured Reagan's victory.Investigative journalist Craig Unger was one of the first reporters covering the October Surprise—initially for Esquire and then Newsweek—and while attempting to unravel the mystery, he was fired, sued, and ostracized by the Washington press corps, as a counter narrative took hold: The October Surprise was a hoax. Though Unger later recovered his name and became a bestselling author on Republican abuses of power, the October Surprise remained his white whale, the project he—as well as legendary investigative journalist, the late Robert Parry—worked on late at night and between assignments.In Den of Spies, Unger reveals the definitive story of the October Surprise, going inside his three-decade reporting odyssey, along with Parry's never-before-seen archives, and sharing startling truths about what really happened in 1980. The result is a real-life political thriller filled with double agents, CIA operatives, slippery politicians, KGB documents, wealthy Republicans, and dogged journalists. A timely and provocative history that presages our Trump-era political scandals, Den of Spies demonstrates the stakes of allowing the politics of the moment to obscure the writing of our history.https://amzn.to/4ohW3GhBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-opperman-report--1198501/support.

In this episode of Climate Brewing, host Susan Oxley speaks with Dr. Corrine Unger, an earth scientist and research fellow at the University of Queensland, about the critical and often overlooked issue of mine closures. Dr. Unger, with extensive experience in the mining industry and government, sheds light on the evolving approach to mine rehabilitation and the significant challenges Australia faces with over 50,000 abandoned mines. Download TranscriptThanks for listening to Project Zion Podcast!Follow us on Facebook and Instagram!Intro and Outro music used with permission: “For Everyone Born,” Community of Christ Sings #285. Music © 2006 Brian Mann, admin. General Board of Global Ministries t/a GBGMusik, 458 Ponce de Leon Avenue, Atlanta, GA 30308. copyright@umcmission.org “The Trees of the Field,” Community of Christ Sings # 645, Music © 1975 Stuart Dauerman, Lillenas Publishing Company (admin. Music Services). All music for this episode was performed by Dr. Jan Kraybill, and produced by Chad Godfrey. NOTE: The series that make up the Project Zion Podcast explore the unique spiritual and theological gifts Community of Christ offers for today's world. Although Project Zion Podcast is a Ministry of Community of Christ. The views and opinions expressed in this episode are those speaking and do not necessarily reflect the official policy or position of Community of Christ.

utr

The environmental issues we face stretch beyond the climate crisis and raise issues regarding things that the Community of Christ holds dear.  For instance, how we respond to environmental issues has a direct effect on the worth of persons... and often it's the indigenous peoples of the land in question. In this episode of Climate Brewing, Susan Oxley hosts Dr. Karin Unger, a research fellow at the University of Queensland, to discuss the impact of mine closures on indigenous communities. With over 50,000 abandoned mines, many affecting indigenous lands, Dr Unger emphasizes the need for better policies and regulations to address these issues and the importance of making space for indigenous people in the conversations regarding just transitions.Find other episodes in the Climate Brewing series.Download TranscriptThanks for listening to Project Zion Podcast!Follow us on Facebook and Instagram!Intro and Outro music used with permission: “For Everyone Born,” Community of Christ Sings #285. Music © 2006 Brian Mann, admin. General Board of Global Ministries t/a GBGMusik, 458 Ponce de Leon Avenue, Atlanta, GA 30308. copyright@umcmission.org “The Trees of the Field,” Community of Christ Sings # 645, Music © 1975 Stuart Dauerman, Lillenas Publishing Company (admin. Music Services). All music for this episode was performed by Dr. Jan Kraybill, and produced by Chad Godfrey. NOTE: The series that make up the Project Zion Podcast explore the unique spiritual and theological gifts Community of Christ offers for today's world. Although Project Zion Podcast is a Ministry of Community of Christ. The views and opinions expressed in this episode are those speaking and do not necessarily reflect the official policy or position of Community of Christ.